Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidaseAndrea Amalfitano, Yuting Chen, Alison McVie‐Wylie et al.|Proceedings of the National Academy of Sciences|1999Cited by 139
Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe diseaseAlison McVie‐Wylie, Robert J. Mattaliano, Hung Do et al.|Molecular Genetics and Metabolism|2008Cited by 96